Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

Children's Hospital of Michigan is treating the first person in Michigan with a newly approved gene-editing therapy for beta ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Keywords: Vitiligo, Artificial Intelligence, Novel Therapies Dermatology, Patient Care, Clinical Research, Diagnostic Tools, Treatment Outcomes, AI in Medicine, Skin Disorders Important Note: All ...